Mr. Pottle's corporate practice is focused on a wide range of complex corporate and securities matters, including mergers and acquisitions, corporate governance, public and private securities offerings, joint ventures, and formation transactions. He represents public and private companies, their boards and committees, and financial sponsors and advisors in a variety of industry sectors from health care to technology. He has counseled multi-billion dollar international companies, as well as Fortune 100 corporations, in sophisticated transactions with an aggregate value exceeding $15 billion.
Steve Pottle is a former chair of the firm’s Health Care Group, which includes teams of corporate, FDA, health policy and health care compliance lawyers and other professionals. He has co-chaired the firm’s Technology Group and also chaired the firm’s Life Sciences Task Force.
Mr. Pottle is listed in The Best Lawyers in America, Chambers USA: America’s Leading Lawyers for Business, “Top Legal Deal Makers” in Atlanta Business Chronicle and Super Lawyers magazine.
Mr. Pottle's corporate practice is focused on a wide range of complex corporate and securities matters, including mergers and acquisitions, corporate governance, public and private securities offerings, joint ventures, and formation transactions. He represents public and private companies, their boards and committees, and financial sponsors and advisors in a variety of industry sectors from health care to technology. He has counseled multi-billion dollar international companies, as well as Fortune 100 corporations, in sophisticated transactions with an aggregate value exceeding $15 billion.
Steve Pottle is a former chair of the firm’s Health Care Group, which includes teams of corporate, FDA, health policy and health care compliance lawyers and other professionals. He has co-chaired the firm’s Technology Group and also chaired the firm’s Life Sciences Task Force.
Mr. Pottle is listed in The Best Lawyers in America, Chambers USA: America’s Leading Lawyers for Business, “Top Legal Deal Makers” in Atlanta Business Chronicle and Super Lawyers magazine. Steve is a member of the American Health Lawyers Association and the Georgia and Atlanta Bar Associations.
He received a J.D. from Vanderbilt University School of Law, where he was a member of the Vanderbilt Law Review. He received a B.A. in business administration and accounting from the University of Washington and attended foreign study programs in Tokyo, Japan and London, England. He has also passed the CPA exam and was a professional with Ernst & Young prior to law school.
- Counsel to public health care services company in $300 million going private transaction.
- Counsel to several Nashville-based diversified health care provider companies in numerous formation, financing, acquisition and restructuring transactions.
- Counsel to one of the largest for-profit hospital chains in the disposition of a health care system to a premier academic medical institution.
- Counsel to European-based medical device company in $750 million acquisition of the cardiac and vascular surgery division of Boston Scientific and in the $865 million tender offer for a U.S. publicly-traded medical device company.
- Counsel to specialty pharmacy company in initial and follow-on public offerings, numerous acquisitions and governance matters and eventual sale for $2.5 billion.
- Company counsel in initial and follow-on public offerings of home health care company.
- Counsel to large dialysis chain in unique roll-up formation, initial and follow-on offerings, numerous acquisitions and governance matters and eventual sale for $4 billion.
- Underwriter counsel in initial and follow-on public offerings of specialty pharmacy company.
- Counsel to financial advisor in sale of home health company.
- Counsel to major academic medical center in a hospital joint venture with one of the largest for-profit hospital chains.
- Counsel to one of the largest for-profit hospital chains in the disposition of a network of hospitals.
- Counsel to health care information technology company in spin-out from a major academic medical center and venture capital financing.
|
|
January 18, 2012
|
|
|
October 13, 2011
|
|
|
September 12, 2011
|
|
|
|
|
|
November 2, 2007
|
|
|
October 26, 2006
|
|
|
|